FDA Inspection 1218963 — Vivus, LLC.

Vivus, LLC. — FEI 3000719979

The FDA completed an inspection of Vivus, LLC. on Sep 8, 2023 in Campbell, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 8, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Campbell, CA (United States)

Additional details

Risk Evaluation and Mitigation Strategies (REMS)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.